2026³â 01¿ù 18ÀÏ ÀÏ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Kaitie Kramer Joins Parse Biosciences as Vice President of Marketing

Veteran biotech executive to head global marketing as company enters next phase of growth
´º½ºÀÏÀÚ: 2024-09-27

SEATTLE -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced that Kaitie Kramer has joined the company as vice president of marketing. She will lead the marketing strategy for the company and its growing portfolio of single cell solutions including Evercode™ Whole Transcriptome, Evercode™ TCR, Evercode™ BCR, and CRISPR Detect platforms.

“As Parse gains market share in the U.S. and abroad, we’re continuing to hire talented people who can lead us through the next phase of our growth,” noted Parse CEO and co-founder Alex Rosenberg, PhD. “Kaitie’s deep level of experience in this market will be a huge asset for Parse and we’re fortunate to have her as part of our leadership team moving forward.”

Kramer brings more than 20 years of commercial biotech experience to the role and joins Parse from Twist Bioscience, where she served as senior director of commercial marketing, overseeing key initiatives to help drive growth and brand awareness. She also brings extensive single cell and general cell biology experience to the role. While serving as Illumina’s first single cell sequencing sales specialist, Kramer was part of the team who helped bring broad awareness to new applications and use cases of single cell sequencing.

Previously, she held senior marketing and business development roles with Thermo Fisher Scientific, Illumina, and Irvine Scientific. She holds a BS in genetics from the University of Wisconsin-Madison.

Noted Kramer, “I’m thrilled to join the Parse Biosciences organization where we’re clearly leading the charge to change the game in single cell biology. The Parse team has a proven track record of delivering innovative, high-quality solutions aimed at making single cell technologies accessible and affordable to all, while also delivering unmatched scalability.” Kramer continued, “It’s inspiring to see how our customers use Parse tools to advance biology. Being part of this team and helping drive the future of single-cell biology with our amazing customers is an honor.”



 Àüü´º½º¸ñ·ÏÀ¸·Î

Barilla Opens Its New Innovation Center to Drive Food Innovation Worldwide
GE HealthCare, Indonesia Partner to Expand Care with 300+ Advanced CT Scanners
Esco Aster, Shine-On Biomedical Ink cGMP Deal for First-in-Class HLA-G Exosome Drug Platform
1GLOBAL Empowers Revolut to Offer Mobile Plans in Poland
Sinovac: Antigua Court Grants Board Control Pending Trial Over Disputed 2025 Shareholder Meeting
SLB Enters Collaboration Agreement to Accelerate New Digital Solutions
Guinea Emerges as West Africa's New Digital Transformation Powerhouse

 

Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase On...
Smarter Cars, Better Journeys: LG and aiMotive Reveal the Next-Gen HPC...
Parse Biosciences, Codebreaker Labs Partner on Scaled Single Cell Tran...
Tecnotree Emerges as CX Catalyst Winner for Impact at The Fast Mode Aw...
Biocytogen Completes STAR Market IPO, Becoming the First ¡°H+A¡± Globa...
Tahoe Therapeutics Picks Parse Biosciences¡¯ GigaLab, Targets 300M Sin...
DNP Achieves 10nm Line Pattern Resolution on Nanoimprint Template for ...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..